Thursday, September 12, 2019

   
 

Plenary Session

Faculty

   
Welcome to IMW17 Organizers of IMW17
History of IMW RA Kyle
IMS President Address: State of the Art for Myeloma in 2019 J San Miguel
   
Precursor Conditions  
Session Chairs RA Kyle / F Davies
Risk factors for MGUS/SMM progression V Rajkumar
Genomic Profiling: How is MGUS/SM different from Active MM? N Bolli
Role of the Microenvironment in MGUS progression M Dhodapkar
MGRS and other Paraprotein Related Conditions JP Fermand
Management of Smoldering Myeloma MV Mateos
New Concepts in Preventing SM Progression I Ghobrial
   
Multiple Myeloma: Diagnosis and Management  
Session Chairs M Boccadoro/V Rajkumar
Diagnostic Criteria and Workup in 2019 S Kumar
How do we use prognostic factors to Guide Treatment Decisions? P Sonneveld
When and how should MRD be evaluated in MM? B Paiva
Should MRD status guide drug development and approval? F. Gay
Challenges with current MM response criteria J Blade
Imaging Approaches for MM E Zamagni
   

Expositions and Lunch

   
Multiple Myeloma Genomics  
Session Chairs R Fonseca/WJ Chng
Somatic Variants in Newly Diagnosed MM H Avet-Loiseau
Clonal Diversity and Evolution in Myeloma N Munshi
Transcriptome of Malignant Plasma Cells G Morgan
Epigenomics of Myeloma C Ott
Signalomics of Malignant Plasma Cells M Rabb 
Importance of Microbiome in MM Growth and Survival L Bergsagel
   
Multiple Myeloma: Current Treatment Approaches  
Session Chairs P Richardson/MV Mateos
Treatment of Newly Diagnosed Myeloma Transplant Eligible M Cavo
Treatment of Newly Diagnosed Myeloma Non-Transplant T Facon
Consolidation Strategies for MM E Staudtmauer
Maintenance Strategies for MM P McCarthy
Treatment Options for Relapsed/Refractory Patients P Moreau
Treatment Options for Later Relapse and Refractory Patients S Lonial
   
Hot Topics in Myeloma  
In 2019, is ASCT the right answer for all transplant eligible MM patients?  
Session Moderators M Cavo/S Zweegman
Panelists - M Mohty/H Goldschmidt/D Siegel/M Attal  
   
In 2019, when is allogeneic transplant the right answer for MM ?  
Session Moderators S Giralt/H Ensele
Panelists - J Wolfe/G Gharton/W Bensinger/TBD  
   
Keynote Addresses  
Are we curing MM in 2019? B Barlogie
What are the critical unanswered questions for MM in 2019? M Dimopoulos
   

Opening Ceremonies and Young Investigator Award
Presentations at the Boston Museum of Science

 

Workshop Organizers

Christopher Patterson
IMW 17 Secretariat

Dana Farber Cancer Institute
Mayor 548
450 Brookline Avenue
Boston, MA 02215
+1 617 632 6285

cpatterson1@partners.org

Join the IMS Today

Enjoy the

benefits of Membership

in the

International Myeloma Society

Become a Member Today

Housing & Registration

Accommodations


c/o SPARGO, Inc.
11208 Waples Mill Road
Suite 112
Fairfax, VA 22030 USA
888-788-1522 (US Toll free)
+ 1 703-449-6418 (International)

Reserve Now

Contact the IMS

International Myeloma Society

Lisa Sikkink, IMS Assistant

International Myeloma Society
Mayo Clinic
Siebens 6-60
200 First Street SW
Rochester, MN 55905
+1 507 284 3725

adminassistant@myelomasociety.org